Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion type Assertion NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_head.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion description "[TLR-2, TLR-1 and TLR-6 were expressed on both HPKs from patients with AD as well as healthy controls without significant differences between these groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_provenance.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion evidence source_evidence_literature NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_provenance.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion SIO_000772 21447101 NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_provenance.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion wasDerivedFrom befree-2016 NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_provenance.
- NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_assertion wasGeneratedBy ECO_0000203 NP883066.RANCEWG8RlvESkkUjd0VStPkpo_NRJ3fyj52YcLKLvcJU130_provenance.